Risk of arterial thromboembolic events in patients with advanced colorectal cancer receiving bevacizumab von Tebbutt, N.C., Murphy, F., Zannino, D., Wilson, K., Cummins, M.M., Abdi, E., Strickland, A.H., Lowenthal, R.M., Marx, G., Karapetis, C., Shannon, J., Goldstein, D., Nayagam, S.S., Blum, R., Chantrill, L., Simes, R.J., Price, T.J.

Volltext